ZIMMER BIOMET HOLDINGS, INC. financials

ZBH CIK 0001136869

Source: EDGAR filings · raw companyfacts JSON · Built 2026-04-25T10:22:40Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 1.47B 1.30B 1.29B 1.17B 1.36B 1.09B
EBITDA 2.19B 2.28B 2.23B 1.62B 1.80B 981.50M
Working Capital 2.54B 2.22B 1.75B 2.07B 1.42B 2.53B
Net Debt 7.16B 5.92B 5.61B 5.54B 7.01B 7.62B
Gross Margin 69.71% 71.46% 71.82% 70.90% 71.29% 20.98%
Operating Margin 13.34% 16.74% 17.28% 10.03% 12.60% 1.36%
Net Margin 8.57% 11.77% 13.85% 3.33% 5.88% -2.27%
Return on Equity (ROE) 5.55% 7.25% 8.20% 1.93% 3.17% -1.14%
Return on Assets (ROA) 3.05% 4.23% 4.76% 1.10% 1.71% -0.57%
Current Ratio 1.9816 1.906 1.6132 1.8774 1.4086 1.9881
Debt-to-Equity 0.6105 0.5172 0.4829 0.4925 0.5837 0.6904
Effective Tax Rate 15.13% 12.68% 3.95% 27.83% 10.72% 91.25%
Cash Conversion Ratio 2.4069 1.659 1.5445 5.8608 3.7331 -8.6717
Accruals Ratio -0.043 -0.0279 -0.0259 -0.0534 -0.0468 -0.055
SBC % of Revenue 1.10% 1.32% 1.35% 1.51% 1.11% 1.20%
CapEx Coverage 7.5595 7.3572 5.4332 7.2177 10.4401 10.7641
Free Cash Flow Per Share $7.41 $6.35 $6.15 $5.56 $6.44 $5.28

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 25.3296 23.8442 24.9385 115.9091 64.5758
P/FCF 12.133 16.6239 19.7758 22.9506 19.1432 28.3428
FCF Yield 8.24% 6.02% 5.06% 4.36% 5.22% 3.53%
EV / EBITDA 16.3409 17.2919 19.778 28.073 26.0008 56.6488
P/S 3.4814 4.3677 5.2043 5.7651 5.8205 7.8309
P/B 2.2569 2.6899 3.0833 3.3285 3.1387 3.935

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 8.23B 7.68B 7.39B 6.94B 6.83B 6.13B
Cost of Goods and Services Sold 2.49B 2.19B 2.08B 2.02B 1.96B 1.82B
Gross Profit 1.29B
Selling, General and Administrative Expense 3.26B 2.93B 2.84B 2.76B 2.84B 2.71B
Operating Income (Loss) 1.10B 1.29B 1.28B 696.30M 860.30M 83.10M
Income Tax Expense (Benefit) 125.70M 131.40M 42.20M 112.30M 53.50M -96.00M
Net Income (Loss) Attributable to Parent 705.10M 903.80M 1.02B 231.40M 401.60M -138.90M
Earnings Per Share, Basic $3.56 $4.45 $4.91 $1.10 $1.93 $-0.67
Weighted Average Number of Shares Outstanding, Basic 198.00M 203.10M 208.70M 209.60M 208.60M 207.00M
Earnings Per Share, Diluted $3.55 $4.43 $4.88 $1.10 $1.91 $-0.67
Weighted Average Number of Shares Outstanding, Diluted 198.70M 203.90M 209.70M 210.30M 210.40M 207.00M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 591.90M 525.50M 415.80M 375.70M 378.10M 802.10M
Assets, Current 5.12B 4.67B 4.61B 4.43B 4.88B 5.08B
Assets 23.09B 21.37B 21.50B 21.07B 23.46B 24.42B
Long-term Debt 1.00B
Liabilities, Current 2.58B 2.45B 2.86B 2.36B 3.47B 2.56B
Long-term Debt, Excluding Current Maturities 6.93B 5.34B 4.87B 5.15B 5.46B 7.63B
Liabilities 10.39B 8.89B 9.01B 9.04B 10.79B 12.22B
Stockholders' Equity Attributable to Parent 12.70B 12.47B 12.48B 12.02B 12.66B 12.19B

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 1.70B 1.50B 1.58B 1.50B 1.20B
Payments to Acquire Property, Plant, and Equipment 224.50M 203.80M 291.10M 187.90M 143.60M 111.90M
Net Cash Provided by (Used in) Investing Activities -1.98B -888.10M -778.90M -503.60M -613.80M
Payments for Repurchase of Common Stock 487.00M 868.00M 692.20M 126.40M
Net Cash Provided by (Used in) Financing Activities 326.00M -484.50M -763.50M -1.31B -421.80M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Income Statement

26 concepts 3 units
Unit US$ · 20 concepts
Label Value Period
Revenue from Contract with Customer, Excluding Assessed Tax 8.23B 2025-01-01 → 2025-12-31
Interest Income (Expense), Net -292.80M 2025-01-01 → 2025-12-31
Inventory Write-down 311.20M 2025-01-01 → 2025-12-31
Cost of Goods and Services Sold 2.49B 2025-01-01 → 2025-12-31
Research and Development Expense (Excluding Acquired in Process Cost) 458.50M 2025-01-01 → 2025-12-31
Costs and Expenses 7.13B 2025-01-01 → 2025-12-31
Amortization of Intangible Assets 665.90M 2025-01-01 → 2025-12-31
Depreciation, Depletion and Amortization, Nonproduction 1.09B 2025-01-01 → 2025-12-31
Goodwill, Impairment Loss 0 2025-01-01 → 2025-12-31
Selling, General and Administrative Expense 3.26B 2025-01-01 → 2025-12-31
Operating Income (Loss) 1.10B 2025-01-01 → 2025-12-31
Gain (Loss) on Investments 14.70M 2025-01-01 → 2025-12-31
Foreign Currency Transaction Gain (Loss), before Tax -14.20M 2025-01-01 → 2025-12-31
Other Nonoperating Income (Expense) 25.50M 2025-01-01 → 2025-12-31
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 830.80M 2025-01-01 → 2025-12-31
Income Tax Expense (Benefit) 125.70M 2025-01-01 → 2025-12-31
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 705.10M 2025-01-01 → 2025-12-31
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 705.10M 2025-01-01 → 2025-12-31
Net Income (Loss) Attributable to Parent 705.10M 2025-01-01 → 2025-12-31
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest -100.00K 2025-01-01 → 2025-12-31
Unit shares · 3 concepts
Unit US$ / share · 3 concepts
Label Value Period
Earnings Per Share, Basic $3.56 2025-01-01 → 2025-12-31
Earnings Per Share, Diluted $3.55 2025-01-01 → 2025-12-31
Common Stock, Dividends, Per Share, Declared $0.96 2025-01-01 → 2025-12-31

Comprehensive Income

17 concepts 1 unit
Unit US$ · 17 concepts
Label Value Period
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax 7.10M 2025-01-01 → 2025-12-31
Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, before Tax 48.70M 2025-01-01 → 2025-12-31
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax -6.70M 2025-01-01 → 2025-12-31
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax 55.60M 2025-01-01 → 2025-12-31
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax 69.80M 2025-01-01 → 2025-12-31
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax -38.90M 2025-01-01 → 2025-12-31
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax -6.30M 2025-01-01 → 2025-12-31
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax 45.30M 2025-01-01 → 2025-12-31
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 57.10M 2025-01-01 → 2025-12-31
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 762.20M 2025-01-01 → 2025-12-31
Other Comprehensive Income (Loss), before Tax -6.50M 2025-01-01 → 2025-12-31
Other Comprehensive Income (Loss), Tax -63.60M 2025-01-01 → 2025-12-31
Other Comprehensive Income (Loss), Net of Tax 57.10M 2025-01-01 → 2025-12-31
OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax -62.70M 2025-01-01 → 2025-12-31
Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, Tax 9.80M 2025-01-01 → 2025-12-31
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax -400.00K 2025-01-01 → 2025-12-31
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax 10.30M 2025-01-01 → 2025-12-31

Balance Sheet

47 concepts 3 units
Unit US$ · 40 concepts
Label Value Period
Cash and Cash Equivalents, at Carrying Value 591.90M as of 2025-12-31
Accounts Receivable, Allowance for Credit Loss, Current 109.80M as of 2025-12-31
Accounts Receivable, after Allowance for Credit Loss, Current 1.70B as of 2025-12-31
Inventory, Net 2.29B as of 2025-12-31
Assets, Current 5.12B as of 2025-12-31
Operating Lease, Right-of-Use Asset 204.20M as of 2025-12-31
Property, Plant and Equipment, Gross 7.26B as of 2025-12-31
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 5.05B as of 2025-12-31
Property, Plant and Equipment, Net 2.21B as of 2025-12-31
Contract with Customer, Asset, after Allowance for Credit Loss 0 as of 2025-12-31
Goodwill 9.95B as of 2025-12-31
Indefinite-lived Intangible Assets (Excluding Goodwill) 675.40M as of 2025-12-31
Finite-Lived Intangible Assets, Gross 10.38B as of 2025-12-31
Finite-Lived Intangible Assets, Accumulated Amortization 6.34B as of 2025-12-31
Intangible Assets, Net (Excluding Goodwill) 4.72B as of 2025-12-31
Other Assets, Noncurrent 1.10B as of 2025-12-31
Contract with Customer, Liability 0 as of 2025-12-31
Estimated Litigation Liability 136.20M as of 2025-12-31
Operating Lease, Liability 233.00M as of 2025-12-31
Assets 23.09B as of 2025-12-31
Accounts Payable, Current 303.00M as of 2025-12-31
Employee-related Liabilities, Current 477.10M as of 2025-12-31
Accrued Liabilities, Current 834.50M as of 2025-12-31
Long-term Debt, Current Maturities 587.10M as of 2025-12-31
Other Liabilities, Current 1.69B as of 2025-12-31
Liabilities, Current 2.58B as of 2025-12-31
Long-term Debt, Excluding Current Maturities 6.93B as of 2025-12-31
Deferred Income Tax Liabilities, Net 244.10M as of 2025-12-31
Other Liabilities, Noncurrent 626.10M as of 2025-12-31
Operating Lease, Liability, Noncurrent 175.50M as of 2025-12-31
Liabilities 10.39B as of 2025-12-31
Common Stock, Value, Issued 3.20M as of 2025-12-31
Additional Paid in Capital, Common Stock 10.18B as of 2025-12-31
Treasury Stock, Value 8.89B as of 2025-12-31
Accumulated Other Comprehensive Income (Loss), Net of Tax -205.70M as of 2025-12-31
Retained Earnings (Accumulated Deficit) 11.61B as of 2025-12-31
Stockholders' Equity Attributable to Parent 12.70B as of 2025-12-31
Stockholders' Equity Attributable to Noncontrolling Interest 8.10M as of 2025-12-31
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 12.71B as of 2025-12-31
Liabilities and Equity 23.09B as of 2025-12-31
Unit shares · 6 concepts
Label Value Period
Preferred Stock, Shares Authorized 250.00M as of 2025-12-31
Preferred Stock, Shares Issued 0 as of 2025-12-31
Preferred Stock, Shares Outstanding 0 as of 2025-12-31
Common Stock, Shares Authorized 1.00B as of 2025-12-31
Common Stock, Shares, Issued 318.70M as of 2025-12-31
Treasury Stock, Common, Shares 123.20M as of 2025-12-31
Unit US$ / share · 1 concept
Label Value Period
Common Stock, Par or Stated Value Per Share $0.01 as of 2025-12-31

Cash Flow Statement

35 concepts 1 unit
Unit US$ · 35 concepts
Label Value Period
Depreciation 427.90M 2025-01-01 → 2025-12-31
Depreciation, Depletion and Amortization 1.09B 2025-01-01 → 2025-12-31
Payments to Acquire Business Two, Net of Cash Acquired 1.39B 2025-01-01 → 2025-12-31
Share-based Payment Arrangement, Noncash Expense 90.20M 2025-01-01 → 2025-12-31
Operating Lease, Payments 67.90M 2025-01-01 → 2025-12-31
Interest Paid, Including Capitalized Interest, Operating and Investing Activities 298.40M 2025-01-01 → 2025-12-31
Deferred Income Tax Expense (Benefit) -87.20M 2025-01-01 → 2025-12-31
IncomeTaxPaidFederalAfterRefundReceived 196.90M 2025-01-01 → 2025-12-31
IncomeTaxPaidStateAndLocalAfterRefundReceived 24.10M 2025-01-01 → 2025-12-31
IncomeTaxPaidForeignAfterRefundReceived 155.90M 2025-01-01 → 2025-12-31
Income Taxes Paid, Net 376.90M 2025-01-01 → 2025-12-31
Capital Expenditures Incurred but Not yet Paid 11.70M 2025-01-01 → 2025-12-31
Increase (Decrease) in Receivables 127.30M 2025-01-01 → 2025-12-31
Increase (Decrease) in Inventories -98.20M 2025-01-01 → 2025-12-31
Increase (Decrease) in Accounts Payable and Accrued Liabilities 101.80M 2025-01-01 → 2025-12-31
Increase (Decrease) in Income Taxes Payable -166.60M 2025-01-01 → 2025-12-31
Increase (Decrease) in Other Operating Assets and Liabilities, Net 11.00M 2025-01-01 → 2025-12-31
Net Cash Provided by (Used in) Operating Activities 1.70B 2025-01-01 → 2025-12-31
Payments to Acquire Property, Plant, and Equipment 224.50M 2025-01-01 → 2025-12-31
Payments to Acquire Intangible Assets 52.40M 2025-01-01 → 2025-12-31
Payments for (Proceeds from) Hedge, Investing Activities 400.00K 2025-01-01 → 2025-12-31
Payments for (Proceeds from) Other Investing Activities 4.60M 2025-01-01 → 2025-12-31
Net Cash Provided by (Used in) Investing Activities -1.98B 2025-01-01 → 2025-12-31
Proceeds from Issuance of Senior Long-term Debt 2.49B 2025-01-01 → 2025-12-31
Maturities of Senior Debt 1.46B 2025-01-01 → 2025-12-31
Payments of Debt Issuance Costs 22.70M 2025-01-01 → 2025-12-31
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 39.70M 2025-01-01 → 2025-12-31
Payments for Repurchase of Common Stock 487.00M 2025-01-01 → 2025-12-31
Payments of Ordinary Dividends, Common Stock 190.30M 2025-01-01 → 2025-12-31
Payment for Contingent Consideration Liability, Financing Activities 25.00M 2025-01-01 → 2025-12-31
Proceeds from (Payments for) Other Financing Activities -17.70M 2025-01-01 → 2025-12-31
Net Cash Provided by (Used in) Financing Activities 326.00M 2025-01-01 → 2025-12-31
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 19.00M 2025-01-01 → 2025-12-31
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 66.40M 2025-01-01 → 2025-12-31
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 591.90M as of 2025-12-31

Notes

122 concepts 5 units
Unit US$ · 88 concepts
Label Value Period
Current Federal Tax Expense (Benefit) 62.90M 2025-01-01 → 2025-12-31
Current State and Local Tax Expense (Benefit) 21.50M 2025-01-01 → 2025-12-31
Current Foreign Tax Expense (Benefit) 128.50M 2025-01-01 → 2025-12-31
Current Income Tax Expense (Benefit) 212.90M 2025-01-01 → 2025-12-31
Deferred Federal Income Tax Expense (Benefit) -120.90M 2025-01-01 → 2025-12-31
Deferred State and Local Income Tax Expense (Benefit) -30.80M 2025-01-01 → 2025-12-31
Deferred Foreign Income Tax Expense (Benefit) 64.50M 2025-01-01 → 2025-12-31
Operating Lease, Liability, Current 57.50M as of 2025-12-31
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense -2.20M 2025-01-01 → 2025-12-31
Prepaid Expense and Other Assets, Current 537.30M as of 2025-12-31
Share-based Payment Arrangement, Expense, after Tax 82.50M 2025-01-01 → 2025-12-31
Share-based Payment Arrangement, Expense, Tax Benefit 7.70M 2025-01-01 → 2025-12-31
EffectiveIncomeTaxRateReconciliationGiltiAmount 47.00M 2025-01-01 → 2025-12-31
EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount 14.80M 2025-01-01 → 2025-12-31
Share-based Payment Arrangement, Exercise of Option, Tax Benefit 200.00K 2025-01-01 → 2025-12-31
Long-term Debt, Fair Value 7.60B as of 2025-12-31
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount -16.50M 2025-01-01 → 2025-12-31
Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount 19.00M 2025-01-01 → 2025-12-31
Inventory, Finished Goods, Net of Reserves 1.83B as of 2025-12-31
Inventory, Work in Process, Net of Reserves 181.00M as of 2025-12-31
Inventory, Raw Materials, Net of Reserves 273.20M as of 2025-12-31
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 3.50M 2025-01-01 → 2025-12-31
Effective Income Tax Rate Reconciliation, Tax Contingency, Domestic, Amount 17.10M 2025-01-01 → 2025-12-31
Dividends, Common Stock, Cash 189.40M 2025-01-01 → 2025-12-31
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount 1.50M 2025-01-01 → 2025-12-31
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount 95.70M 2025-01-01 → 2025-12-31
Litigation Settlement, Expense 22.70M 2025-01-01 → 2025-12-31
Finite-Lived Intangible Asset, Expected Amortization, Year One 633.60M as of 2025-12-31
Finite-Lived Intangible Asset, Expected Amortization, Year Two 619.80M as of 2025-12-31
Finite-Lived Intangible Asset, Expected Amortization, Year Three 613.60M as of 2025-12-31
Finite-Lived Intangible Asset, Expected Amortization, Year Four 564.90M as of 2025-12-31
Revenue, Remaining Performance Obligation, Amount 0 as of 2025-12-31
Finite-Lived Intangible Asset, Expected Amortization, Year Five 448.40M as of 2025-12-31
Treasury Stock, Value, Acquired, Cost Method 484.30M 2025-01-01 → 2025-12-31
Contract with Customer, Refund Liability, Current 243.00M as of 2025-12-31
Deferred Tax Assets, Operating Loss Carryforwards 459.30M as of 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value 0 as of 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 1.00M 2025-01-01 → 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value 0 as of 2025-12-31
Deferred Tax Assets, Tax Credit Carryforwards 121.20M as of 2025-12-31
Goodwill, Foreign Currency Translation Gain (Loss) 110.60M 2025-01-01 → 2025-12-31
Deferred Tax Assets, Capital Loss Carryforwards 123.70M as of 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value 0 as of 2025-12-31
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost 41.20M as of 2025-12-31
Goodwill, Gross 11.28B as of 2025-12-31
Goodwill, Impaired, Accumulated Impairment Loss 1.33B as of 2025-12-31
Lease, Cost 64.30M 2025-01-01 → 2025-12-31
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts 28.80M as of 2025-12-31
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 38.10M 2025-01-01 → 2025-12-31
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Contingencies 23.70M as of 2025-12-31
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities 94.20M as of 2025-12-31
Deferred Tax Assets, Inventory 266.70M as of 2025-12-31
Lessee, Operating Lease, Liability, to be Paid, Year One 64.20M as of 2025-12-31
Lessee, Operating Lease, Liability, to be Paid, Year Two 52.80M as of 2025-12-31
Deferred Tax Assets, Unrealized Currency Losses 28.70M as of 2025-12-31
Lessee, Operating Lease, Liability, to be Paid, Year Three 37.50M as of 2025-12-31
Lessee, Operating Lease, Liability, to be Paid, Year Four 28.40M as of 2025-12-31
Lessee, Operating Lease, Liability, to be Paid, Year Five 21.00M as of 2025-12-31
Lessee, Operating Lease, Liability, to be Paid, after Year Five 59.10M as of 2025-12-31
Deferred Tax Assets, Investments 52.60M as of 2025-12-31
Lessee, Operating Lease, Liability, to be Paid 263.00M as of 2025-12-31
Deferred Tax Assets, Other 1.60M as of 2025-12-31
Deferred Tax Assets, Gross 1.39B as of 2025-12-31
Deferred Tax Assets, Valuation Allowance 573.00M as of 2025-12-31
Deferred Tax Assets, Net of Valuation Allowance 817.00M as of 2025-12-31
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 30.00M as of 2025-12-31
Deferred Tax Liabilities, Gross 799.20M as of 2025-12-31
Deferred Tax Assets, Net 17.80M as of 2025-12-31
Deferred Tax Liabilities, Property, Plant and Equipment 153.00M as of 2025-12-31
Deferred Tax Liabilities, Leasing Arrangements 49.10M as of 2025-12-31
Deferred Tax Liabilities, Intangible Assets 534.60M as of 2025-12-31
Deferred Tax Liabilities, Other 13.40M as of 2025-12-31
Defined Contribution Plan, Cost 56.60M 2025-01-01 → 2025-12-31
Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax -271.80M 2025-01-01 → 2025-12-31
Operating Loss Carryforwards, Valuation Allowance 391.00M as of 2025-12-31
Tax Credit Carryforward, Valuation Allowance 47.80M as of 2025-12-31
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net 46.10M as of 2025-12-31
Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net -800.00K as of 2025-12-31
Unrecognized Tax Benefits 247.40M as of 2025-12-31
Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions 1.40M 2025-01-01 → 2025-12-31
Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 300.00K 2025-01-01 → 2025-12-31
Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 4.80M 2025-01-01 → 2025-12-31
Unrecognized Tax Benefits, Increase Resulting from Acquisition 600.00K 2025-01-01 → 2025-12-31
Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 500.00K 2025-01-01 → 2025-12-31
Unrecognized Tax Benefits that Would Impact Effective Tax Rate 213.20M as of 2025-12-31
Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months 30.70M as of 2025-12-31
Income (Loss) from Continuing Operations before Income Taxes, Domestic -127.50M 2025-01-01 → 2025-12-31
Income (Loss) from Continuing Operations before Income Taxes, Foreign 958.30M 2025-01-01 → 2025-12-31
Unit shares · 12 concepts
Label Value Period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 4.59M as of 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0 2025-01-01 → 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 91,000 2025-01-01 → 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3,000 2025-01-01 → 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 682,000 2025-01-01 → 2025-12-31
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 700,000 2025-01-01 → 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 4.59M as of 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 4.59M as of 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 2.78M as of 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 1.83M 2025-01-01 → 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 683,000 2025-01-01 → 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 438,000 2025-01-01 → 2025-12-31
Unit US$ / share · 11 concepts
Label Value Period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $125.91 as of 2025-12-31
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $0.00 2025-01-01 → 2025-12-31
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price $92.72 2025-01-01 → 2025-12-31
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price $128.14 2025-01-01 → 2025-12-31
Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price $116.93 2025-01-01 → 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $125.91 as of 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $125.91 as of 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $108.83 as of 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value $98.00 2025-01-01 → 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value $102.19 2025-01-01 → 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value $114.40 2025-01-01 → 2025-12-31
Unit Segment · 1 concept
Label Value Period
Number of Operating Segments 3 2025-01-01 → 2025-12-31

Other

2 concepts 1 unit
Unit US$ · 2 concepts
Label Value Period
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture 113.30M 2025-01-01 → 2025-12-31
Stock Issued During Period, Value, Acquisitions 27.80M 2025-01-01 → 2025-12-31

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (ZBH CIK 0001136869), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.